Siemens Healthineers buys shares: RBC lifts target for Siemens Healthineers stock to EUR 48.00

Published on 10/20/2026 at 10:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC set its target at EUR 48.00 after EUR 45.00. Siemens Healthineers stock costs EUR 41.01 on October 20, 2026, 0.05 percent below Xetra close.

Corporate actions and dates

Siemens Healthineers bought back 55,000 shares between October 12 and October 18, 2026.
RBC raised its price target from EUR 45.00 to EUR 48.00 on October 15, 2026.
Siemens Healthineers stock trades at EUR 41.01 at 10:40 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.05 percent below the Xetra close of October 19, 2026.
The fiscal 2026 fourth-quarter results are scheduled for November 5, 2026.

3D-Architekturrender eines modernen Glas-Bürogebäudes mit Grünanlagen — Siemens Healthineers DE000SHL1006 illustriert modernes Architektur-Render eines unmarkierten Glas-Bürocampus mit gepflegten Grünflächen und Platz, Illustration mit AI erstellt.

Siemens Healthineers (ISIN DE000SHL1006) bought back 55,000 shares between October 12 and October 18, 2026, while RBC raised its price target from EUR 45.00 to EUR 48.00. The latest transactions and analyst move were reported by Boerse Express. At 10:40 a.m. CEST, the stock was trading at EUR 41.01 at Lang & Schwarz on October 20, 2026, minus 0.05 percent versus the Xetra close of October 19, 2026 at EUR 41.03.

Buyback adds a fresh market signal

The buyback has reached 3,529,346 shares since its June 1, 2026 launch, giving the latest announcement a concrete scale. The company is also narrowing its ultrasound activity toward interventional imaging and image-guided therapies, while continuing service for existing customers, according to Boerse Express.

What does the target change mean?

RBC's October 15, 2026 research note raised the target from EUR 45.00 to EUR 48.00 and kept an Outperform rating, citing the Accela radiation therapy system. That target is EUR 6.97 above the Lang & Schwarz price, but the small daily move leaves the next earnings report as the clearer test of execution.

Three dated events frame the story

On July 31, 2026, Siemens Healthineers reported a Q3 fiscal 2026 equipment book-to-bill ratio of 1.27, according to the Yahoo Finance transcript. On October 15, 2026, RBC set the EUR 48.00 target after EUR 45.00. On October 19, 2026, the company disclosed a further 55,000-share buyback tranche.

Which dates come next?

Siemens Healthineers lists November 5, 2026 for fiscal fourth-quarter results and the analyst call, followed by a November 6, 2026 US roadshow on its investor-relations page. The fiscal 2026 outlook from the Q3 call was 3.5 to 4.0 percent comparable revenue growth and adjusted earnings per share of EUR 2.35 to EUR 2.45, with the range raised by EUR 0.15 after tariff refunds.

Price stays near the Xetra close

The current euro quotation is only EUR 0.02 below the Xetra reference, so the market has not yet assigned a large daily move to the buyback and target revision. Siemens Healthineers has a market capitalization of EUR 45.9 billion and a 52-week range of EUR 32.81 to EUR 49.71 as of October 20, 2026.

The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.